Equity Capital Markets

The Blackwall Legal Equity Capital Markets advisors have over 35 years combined experience in corporate finance and securities law. We have acted on many stock exchange listings and capital raisings by public companies and we regularly act for leading local, national and international broking firms on underwriting, lead management and private placement arrangements.

Our Equity Capital Markets team understands that advising on corporate, transactional and financing matters require professionalism and commerciality but also great flexibility and agility, which the larger corporate law firms cannot deliver.

Our advisors have developed strong relationships with the ASX and ASIC over the years in order to ensure we are fully conversant with the latest regulatory requirements. Our Special Counsel Jamie Ogilvie, previously holding senior positions with the ASX, the corporate securities regulator ASIC and stockbroking firms, ensure that Blackwall’s Equity Capital Markets expertise has been born from both extensive legal advisory and internal working knowledge within the regulatory bodies.

Our core capabilities in Equity Capital Markets include:

  • Due diligence
  • Regulatory compliance
  • Adviser and broker mandates
  • Initial public offerings
  • Stock exchange listings
  • Project finance mergers
  • Convertible notes and convertible loan arrangements
  • Employee incentive schemes
  • Underwriting and sub-underwriting agreements
  • Rights issues and entitlement offerings

Recent Experience

Our recent experience includes assisting with substantial placements in ASX-listed companies and the listing via reverse-takeover of a number of businesses in particularly challenging regulatory environments such as medicinal cannabis and internationally-registered technology businesses.

Meet our Team

Chris Pearce

Rob McKenzie

Jamie Ogilvie
Special Counsel

Hamish Taylor
Senior Associate

Insights & Publications

Ausmex Mining Group Commences Trading
May 30, 2017

Ausmex Mining Group Limited (ASX:AMG) commenced trading today on ASX following its acquisition of the Ausmex Mining...[Read More]

Medical Cannabis Group Debuts on ASX
February 3, 2017

Today AusCann Group Holdings Limited (ASX:AC8) commenced trading on ASX after a reverse takeover of TW Holdings...[Read More]